Chemotherapy combats early-stage colorectal cancer
Innovative use of chemotherapy prior to surgery to treat colorectal cancer has shown very promising results in a recent clinical study with CHÉOS Scientist Dr. Carl Brown.
Read MoreJanuary 10, 2022
With more than 75 scientists, research at CHÉOS encompasses a wide breadth of health areas. We highlight some of these projects here.
View All Posts
Innovative use of chemotherapy prior to surgery to treat colorectal cancer has shown very promising results in a recent clinical study with CHÉOS Scientist Dr. Carl Brown.
Read More
Cardiac CT imaging provides a long-term warranty for emergency department patients with chest pain
Read More
CHÉOS experts were commissioned to conduct an evaluation to support the implementation and development of the Abbotsford-based program
Read More
March 11 is World Kidney Day and March is Kidney Month. CHÉOS Scientist Dr. Jag Gill is working to reduce cultural inequities to living kidney donation and transplantation
Read More
CHÉOS Scientist Dr. Sarah Munro investigated what factors influence shared decision-making between care providers and parents-to-be who have previously undergone a C-section
Read MoreCHÉOS investigators and research support staff are responding to the COVID-19 pandemic. Current projects include examining mental wellness during a pandemic, the impact of school disruptions, treatment options for COVID-19 and identifying workplace risks that may increase the risk of transmission to paramedics. Our investigators have also shared their expertise in a number of areas related to the pandemic.
View All Posts
CHÉOS Scientist Dr. Mieke Koehoorn works to track and link workplace hazards to prevent chronic disease and shares why COVID-19 outbreaks happened in some unexpected areas
Read More
Understanding COVID-19 vaccine confidence in people living with HIV in Canada
Read More
Dr. Daniel Vigo discusses the significance of combining the support provided by community peers with digital tools to help tackle the global mental health crisis
Read More
Keeping families connected with technology both during and after the pandemic
Read More
The COVID-19 pandemic has catalyzed an increase in the use of digital technology and highlighted its importance in providing essential health care
Read MoreCHÉOS is active in a number of clinical research areas focused in improving patient care. In addition to cardiology, mental health, nephrology, critical care, and HIV research, our investigators undertake studies involving older adults and those who are critically or chronically ill, with the goal of reducing morbidity and mortality and enhancing quality of life. We do this in two main ways: by putting patients first and informing practice.
View All Posts
Dr. Eugenia Oviedo-Joekes answers some key questions about the decriminalization of illegal drugs — and how it could help save lives in B.C.
Read More
CHÉOS Postdoc aims to close the gap in cardiac arrest survival among people with mental illness
Read More
CHÉOS Scientist Dr. Annalijn Conklin aims to understand how gender and changes in social ties can impact blood pressure and body weight in an aging population
Read More
CHÉOS Scientist Dr. Farinaz Havaei is implementing a staffing tool in long-term care settings to improve nurses’ workload management
Read More
Her passion for problem-solving combined with an appreciation of blood's beauty influenced CHÉOS Scientist Dr. Aggie YY Lee to become a hematologist specializing in thrombosis research
Read MoreCHÉOS investigators are at the forefront of health outcomes research, including health economics, pharmacoeconomics and patient-reported outcomes. Their work evaluates the effectiveness of health interventions in populations to inform policies, transforming health systems at the local, national and international levels in the future.
View All Posts
“Go outside and play” is a common phrase echoed by parents across the globe, but what if where you play impacts your future health?
Read More
Dr. Eugenia Oviedo-Joekes answers some key questions about the decriminalization of illegal drugs — and how it could help save lives in B.C.
Read More
In Part 2 of our series on rare diseases, Dr. Larry Lynd discusses what the future could look like for the diagnosis and treatment of rare genetic disorders
Read More
CHÉOS Scientist Dr. Brian Grunau says results from the first peer-reviewed study in North America on COVID-19 mRNA vaccines could inform vaccination policies
Read More
While people understood public health guidelines, they did not adhere to them, citing need for food, medication & fresh air
Read MoreThe Evidence Speaks Series is a recurring feature highlighting the latest in CHÉOS research. This series features summaries of select publications and is designed to keep the media and the research community up-to-date with CHÉOS’ current research results in the health outcomes field. To ensure this research is quick and easy to share, we are now providing social cards that you are free to save and use as you see fit.
View All Posts
This edition includes research on treatment coverage for depression, at-home yoga for older adults with dementia, and risk of death among patients with substance-induced psychosis
Read More
This edition includes preparing patients for colorectal surgery, exome sequencing's impact on health care utilization, and cardiovascular events in people with glomerular diseases
Read More
Research in this edition covers young people with mental health concerns, physical activity in South Asian adults, and management of patients presenting with atrial fibrillation
Read More
This edition highlights research evaluating patient involvement in clinical trial design, detecting prior COVID-19 infections, and the effect of wildfires on respiratory health
Read More
In recognition of Kidney Month, this edition features research on COVID vaccines and dialysis patients, self-management of glomerular disease, and sleep apnea's impact on CKD progression
Read MoreThe Centre is comprised of over 135 staff members and more than 75 scientists, including Canada Research Chairs, Michael Smith Foundation for Health Research Scholars, and Canadian Institutes of Health Research Investigators. CHÉOS expertise and research are widely shared through our collaborations with other organizations, and to help educate and inform the public. Our biweekly newsletter features key stories, updates and announcements from our CHÉOS community.
View All Posts
Spring 2022 WiPs highlighted the research of CHÉOS Scientists Drs. Alana Flexman, Nick Bansback, Mark Harrison, Ricky Turgeon & Mary De Vera.
Read More
Discover news, upcoming events, grants opportunities, and more for the first half of June
Read More
Discover some of the latest news and updates from the weeks of May 23 & 30
Read More
CHÉOS Postdoc aims to close the gap in cardiac arrest survival among people with mental illness
Read MoreCHÉOS investigators are leading experts in their fields. Here is the latest media coverage featuring our people.
View All Posts
The Barer-Flood Prize is awarded to the highest ranking Senior-Career Investigators in the CIHR Project Grant competition
Read More
VANCOUVER, December 1, 2021 - The first peer-reviewed study in North America examining the timing between the first and second doses of COVID-19 mRNA vaccines shows that a longer dose interval leads to a stronger immune response.
Read More
All the latest news from CHÉOS from the weeks of August 30 & September 6
Read More
Collaboration between mental health and emergency medicine researchers aims to repair fragmentation in B.C. health system
Read More
CHÉOS Scientist Dr. Brian Grunau is PI of this study, which will also determine how many paramedics have had COVID-19 and will investigate how long antibodies last
Read MoreIn addition to leading our own studies, the Centre’s other primary function is to support clinical investigators and researchers in conducting high-quality health research. From design to execution, CHÉOS provides a broad range of support services. Some of these resources are shared here.
View All Posts
Health Canada has recently announced a reduction of the retention period for clinical trial records for drugs, biologics and natural health products from 25 years to 15 years.
Read More
CHÉOS Scientist Dr. Anita Ho discusses the concept of vulnerability when it comes to participation in clinical research.
Read More
The 18th installment in our Clinical Research 101 series is by Project Manager Allison Coleman, and discusses adverse events in clinical research, how to collect and report them, and why they're important
Read More
CHÉOS methodologists are available to support the collection and analysis of qualitative data and the interpretation of this information
Read More
CHÉOS Project Manager Shoshana Parker shares an insight into the role of clinical research coordinators in clinical trials
Read More
